Sanofi Gets FDA Approval for Hemophilia Drug
24 Février 2023 - 07:33AM
Dow Jones News
By Adria Calatayud
Sanofi SA said the U.S. Food and Drug Administration has
approved its Altuviiio drug, a once weekly treatment for hemophilia
A.
The French pharmaceutical company said this is the first
approval of the drug, previously referred to as efanesoctocog alfa,
and that regulatory submission in the European Union is expected in
the second half of this year.
The FDA had granted priority review to the drug in August and
designed it a breakthrough therapy in May.
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
February 24, 2023 01:18 ET (06:18 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Sanofi (EU:SAN)
Graphique Historique de l'Action
De Mai 2023 à Juin 2023
Sanofi (EU:SAN)
Graphique Historique de l'Action
De Juin 2022 à Juin 2023
